Subscribe for More Information on Breast Cancer Research
Stay ahead in breast cancer research! Subscribe now for updates on breakthrough drug developments, innovative therapies, and cutting-edge prevention strategies.
Breast Cancer Therapeutic Development All in One Place - Your Ultimate Guide to Comprehensive Preclinical Solutions
We offer a one-stop platform for comprehensive breast cancer drug development, tumor model construction, and basic research services, empowering researchers to accelerate breakthrough therapeutic discoveries.
Get a Quote
Breast cancer is characterized by the presence of malignant tumors in breast tissue. Its development is influenced by various factors, including genetic mutations, hormone levels, family medical history, and lifestyle choices. Breast cancer can originate in the lobules, which are glands responsible for milk production, or in the ducts, which are the channels that transport milk to the nipples.
Common Types of Breast Cancer
Current treatment options for breast cancer encompass surgery, radiotherapy, chemotherapy, endocrine therapy, and targeted therapy. In the realm of drug research, targeted therapies such as Herceptin (trastuzumab) and endocrine therapies like Tamoxifen have been effectively utilized in breast cancer treatment. In recent years, researchers have made significant strides in immunotherapy—such as PD-1/PD-L1 inhibitors—and have advanced new targeted therapies, including CDK4/6 inhibitors and PARP inhibitors.
What Challenges Exist in Breast Cancer Drug Development?
- Tumor heterogeneity makes it difficult to treat uniformly.
- Models are not accurate enough, which affects predictions.
- The complexity of the tumor microenvironment is difficult to simulate.
- New targets are difficult to verify.
- Toxic side effects are difficult to assess.
- Pharmacokinetic studies are complex.
Despite the challenges in breast cancer drug development, the outlook remains promising. Advances in biomarkers and genome sequencing enhance diagnostic accuracy and targeted therapies. Nanotechnology and innovative delivery systems improve efficacy and reduce side effects. With multidisciplinary collaboration and ongoing innovation, we remain confident in overcoming obstacles.
What Are the Prevalent Therapeutic Targets for Breast Cancer Treatment?
| Immune Checkpoint Inhibitor | PD-1, PD-L1, CTLA-4 |
| Cancer Growth Inhibitor | CDK, VEGF–VEGFR, PI3K/AKT/mTOR Pathway, PARP |
| Cytokine and Chemokine Pathway Inhibitor | TNF-α, IL-1, IL-6, Chemokine receptors |
| Metabolic Inhibitor | Glutamine and Arginine, Adenosine, Kynurenine |
| Protein Kinase Inhibitor | EGFR, HER2, ALK |
| Cancer Stem Cells Inhibitor | CDK, Notch, Wnt |
| TAM Modulator | EGFR, AXL, MER, TYRO3 |
| NK Modulator | NKG2D, NKp30, NKp44, NKp46, NKG2A, KIR |
| lAP Inhibitor | XIAP, cIAP1, NF-κB |
| Autophagy Inhibitor | VPS34, ATG, mTOR, Beclin 1 |
Target Identification
Identify key cytokines and chemokines linked to cancer progression via research and bioinformatics.
Hit Discovery
Using HTS and virtual screening, we identify lead compounds that inhibit selected targets.
Lead Optimization
Using SBDD-guided iterations in medicinal chemistry, we improve lead compounds’ potency, selectivity, and pharmacokinetics.
In vitro and in vivo Validation
Lead compounds undergo in vitro and in vivo studies to evaluate efficacy, safety, and mechanisms.
Combination Therapy Assessment
The synergy of cytokine and chemokine pathway inhibitors with chemotherapy, immunotherapy, and targeted therapy is assessed.
What Molecular Types Are Present in Breast Cancer Therapies?
What Type of Breast Cancer Model Is Required?
| Breast Cancer Animal Models | Applications in breast cancer include studying its occurrence and development in vivo. |
| 3D Tumor Model for Breast Cancer | Applications in breast cancer include screening of anti-tumor drug compounds and validation of treatment methods. |
| Breast Cancer Cell Models | Applications in breast cancer focus on drug testing for tumor prevention and treatment. |
Technology Platform
Genomics Platform
- Sequencing Technology: Utilizes second and third-generation sequencing for analyzing cancer-related genomic alterations.
- Gene Editing: Employs CRISPR-Cas9 for functional analysis and validation of gene targets.
Proteomics Platform
- Mass Spectrometry: Identifies and quantifies proteomic composition and modifications.
- Protein Interaction Analysis: Uses techniques like yeast two-hybrid and co-precipitation to explore protein interactions.
Metabolomics Platform
- Chromatography-Mass Spectrometry: Analyzes metabolite changes and pathways.
- Nuclear Magnetic Resonance (NMR): Non-invasive assessment of metabolite structures and dynamics.
- ICP-MS: Determines trace element concentrations in samples to understand elemental shifts in cancer tissues.
Cell Biology Platform
- High-Content Imaging: Examines cellular morphology and drug effects.
- Flow Cytometry: Analyzes cell surface markers and categorizes cells.
Bioinformatics Platform
- Data Analysis: Processes and analyzes high-throughput data like RNA-seq and ChIP-seq.
- Systems Biology Modeling: Simulates biological processes and networks using mathematical models.
Cell and Animal Models
- In Vitro Cell Culture: Researches cellular mechanisms and screens drugs.
- Animal Models: Studies cancer biology and drug responses in vivo.
High-Throughput Screening Platform
- Compound Screening: Evaluates effects of numerous chemicals on cancer cell viability.
- Gene Screening: Screens genes impacting cancer phenotypes using RNA interference or CRISPR libraries.
Immunology Platform
- CyTOF: Conducts high-dimensional analyses of immune cell types and states.
- ELISA & Flow Cytometry: Detects and quantifies immune markers.
Customers Showed the Highest Level of Interest
Small Molecule Drug
Comprehensive services for developing small molecule drugs that offer targeted and efficient treatment options for breast cancer.
Therapeutic Antibody
Cutting-edge solutions for creating therapeutic antibodies that specifically target breast cancer cells.
Breast Cancer Vaccine
Advanced vaccine development services focused on creating therapeutic vaccines to stimulate the immune system to fight breast cancer.
Animal Modeling of Breast Cancer
Developing animal models to study the mechanisms and potential treatments of breast cancer.
Breast Cancer 3D Spheroid Model
Utilizing three-dimensional spheroid cultures to mimic the tumor microenvironment for breast cancer research.
Biomarker Identification
Identifying specific biological markers for early detection, diagnosis, and treatment monitoring of breast cancer.
Preclinical Research for Breast Cancer
Conducting laboratory studies to evaluate the efficacy and safety of new breast cancer treatments before clinical trials.
Breast Cancer Basic Research
Investigating the fundamental biological processes and genetic factors involved in the development and progression of breast cancer.
Expertise
Leverage the experience of seasoned researchers with a deep understanding of cancer biology and metabolism.
Advanced Technologies
Access the latest tools and methodologies for accurate and reliable data.
Customized Solutions
Tailor our services to meet your unique research needs and objectives.
Timely Delivery
Benefit from our commitment to efficiency and timely project completion.
Comprehensive Support
Enjoy end-to-end support from experimental design to data analysis, ensuring research success.
FAQs
What is the difference between targeted therapy and chemotherapy in breast cancer treatment?
Targeted therapy involves drugs that specifically target cancer cell pathways, while chemotherapy uses drugs that kill rapidly dividing cells indiscriminately. Targeted therapy often has fewer side effects compared to chemotherapy.
What types of preclinical models are commonly used for breast cancer research?
There are several types of preclinical models used in breast cancer research, including:
- Cell line models: Cancer cells that are cultured in vitro.
- Xenograft models: Human breast cancer cells or tissue are implanted into immunocompromised mice to study tumor growth and drug response.
- Genetically engineered mouse models (GEMMs): Mice are genetically modified to develop breast cancer spontaneously.
- Patient-derived xenografts (PDX): Tumors taken directly from patients are implanted into mice, better preserving the tumor microenvironment and genetic characteristics.
- 3D culture models: Organoid or spheroid cultures that mimic the 3D structure of tumors.
How are biomarkers used in breast cancer drug development?
Biomarkers help in identifying patients most likely to benefit from a drug, predicting response to treatment, and monitoring treatment effectiveness, aiding in personalized medicine approaches.
Workflow of Our Services
- Consultation and Experimental Design: We work closely with you to understand your research objectives and design customized experiments.
- Sample Preparation and Assay Setup:You provide the necessary samples, and our skilled team handles sample preparation and assay setup with meticulous attention to detail.
- Assay Execution: We perform the cell-based assays using advanced technologies and optimized protocols to ensure reliable and reproducible results.
- Data Acquisition and Analysis:We employ sophisticated data acquisition systems and utilize cutting-edge analysis tools to extract meaningful insights from the obtained data.
- Results Delivery and Interpretation: We provide comprehensive reports summarizing the results of the assays,along with expert interpretation and insights.